Home

Bharat Immunological & Biological Corporation PE Ratio

Image

Bharat Immunological & Biological Corporation Ltd

NSE: BHARATIMMUNOLOG

PE

-

Last updated on: May 10, 2025

Key Highlights

  • The P/E Ratio of Bharat Immunological & Biological Corporation Ltd is 0 as of 10 May 15:30 PM .
  • The P/E Ratio of Bharat Immunological & Biological Corporation Ltd changed from 0 on March 2020 to 0 on March 2023 . This represents a CAGR of 0.0% over 4 years.
  • The Latest Trading Price of Bharat Immunological & Biological Corporation Ltd is ₹ 21.89 as of 09 May 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.1 to 40.1 in 5 years. This represents a CAGR of 13.70%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.1. The PE Ratio of Pharmaceuticals industry is 40.1. The PE Ratio of Retail industry is 139.8. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Bharat Immunological & Biological Corporation Ltd

No data available

Company Fundamentals for Bharat Immunological & Biological Corporation Ltd

Image

Bharat Immunological & Biological Corporation Ltd

NSE: BHARATIMMUNOLOG

Share Price

₹ 21.89

-0.45 (-2.01%)

stock direction

Last updated on: May 09, 2025

Market Price of Bharat Immunological & Biological Corporation Ltd

1M

1Y

3Y

5Y

Monitoring Bharat Immunological & Biological Corporation Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
09 May 202521.89
08 May 202522.34
07 May 202522.12
06 May 202522.06
05 May 202522.5
02 May 202522.7
30 Apr 202522.91
29 Apr 202523.33
28 Apr 202523.13
25 Apr 202523.42

SWOT Analysis Of Bharat Immunological & Biological Corporation Ltd

Strength

0

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Bharat Immunological & Biological Corporation Ltd

Asset Value vs Market Value of Bharat Immunological & Biological Corporation Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Bharat Immunological & Biological Corporation Ltd94.52
Sun Pharmaceutical Industries Ltd418648
Divis Laboratories Ltd159310
Cipla Ltd119410
Torrent Pharmaceuticals Ltd106184
Mankind Pharma Ltd99570

PE Ratio of Bharat Immunological & Biological Corporation Ltd Explained

94.52

Market cap

-18

Earnings

0.0X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Bharat Immunological & Biological Corporation Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Bharat Immunological & Biological Corporation Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Bharat Immunological & Biological Corporation Ltd

No data available

* All values are in %

About Bharat Immunological & Biological Corporation Ltd

  • The Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science and Technology.
  • BIBCOL was incorporated in 1989.
  • The Company is engaged in the manufacture of Oral Polio Vaccine (OPV) , Zinc Tablets and Diarehha management Kit and BIB Sweet Tablets. The company's manufacturing unit is located in Bulandshahr Dist., Uttar Pradesh.
  • BIBCL installed a plant of 100 mln units.
  • Commercial production of the OPV started from Jan'96. The company has received firm orders for supply of OPV from the Ministry of Health and Family Welfare, Government of India, for use in the national immunisation programme.

Bharat Immunological & Biological Corporation Ltd News Hub

Bharat Immunological & Biolog.Corp. to hold board meeting

Bharat Immunological & Biolog.Corp. will hold a meeting of the Board of Directors of the Company on

Read more

10 Aug 24

Bharat Immunological & Biological Corporation Ltd leads gainers in 'B' group

Bodhi Tree Multimedia Ltd, Mangal Credit & Fincorp Ltd, Innovana Thinklabs Ltd and Bartronics India

Read more

06 Jan 25

Bharat Immunological & Biological Corporation Ltd leads losers in 'B' group

Relicab Cable Manufacturing Ltd, Precision Wires India Ltd, Brainbees Solutions Ltd and Flair Writin

Read more

08 Jan 25

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Bharat Immunological & Biological Corporation Ltd

What is the current PE Ratio of Bharat Immunological & Biological Corporation Ltd?

The Current PE Ratio of Bharat Immunological & Biological Corporation Ltd is 0.0 as on 10 May 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.1 as on 10 May 2025.

What was the PE Ratio of Bharat Immunological & Biological Corporation Ltd last year?

The PE Ratio of Bharat Immunological & Biological Corporation Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Bharat Immunological & Biological Corporation Ltd indicate about its stock?

The PE Ratio of Bharat Immunological & Biological Corporation Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Bharat Immunological & Biological Corporation Ltd.

What is the PE Ratio Growth of Bharat Immunological & Biological Corporation Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Bharat Immunological & Biological Corporation Ltd grew by -% whereas, the EPS ratio grew by 7.5.

How does the PE ratio of Bharat Immunological & Biological Corporation Ltd compare to industry peers?

The PE ratio of Bharat Immunological & Biological Corporation Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Bharat Immunological & Biological Corporation Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Bharat Immunological & Biological Corporation Ltd PE Ratio.

What factors influence the PE ratio of Bharat Immunological & Biological Corporation Ltd PE Ratio?

The PE ratio of Bharat Immunological & Biological Corporation Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Bharat Immunological & Biological Corporation Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Bharat Immunological & Biological Corporation Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Bharat Immunological & Biological Corporation Ltd PE Ratio?

You can check the latest PE ratio of Bharat Immunological & Biological Corporation Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Bharat Immunological & Biological Corporation Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Bharat Immunological & Biological Corporation Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Bharat Immunological & Biological Corporation Ltd PE Ratio predict future stock performance?

While the Bharat Immunological & Biological Corporation Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions